Cullinan Oncology LLC (CGEM) Financials

$22.09

$-0.07 (-0.32%)

As on 04-Sep-2026 19:31EDT

Market cap

$1,358 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Operating Revenue	--	--	--	--	--	18.94
Cost of Revenue	0.16	0.31	0.31	0.31	0.09	0.05
Gross Profit	-0.16	-0.31	-0.31	-0.31	-0.09	18.94
Operating Expenses	221.81	241.65	196.61	191.09	-144.65	86.90
Operating Profit (EBIT)	-221.81	-241.65	-196.92	-191.09	144.65	-67.95
Other Income	--	--	--	--	6.67	0.47
Profit before Tax	-204.69	-219.88	-167.46	-169.22	151.32	-67.49
Provision for Tax	--	--	0.12	-14.12	42.12	-2.45
Profit after Tax (Net Income)	-204.69	-219.88	-167.38	-153.16	111.21	-65.04
Minority Interest	--	--	0.19	1.94	-2.02	-1.92
Consolidated Profit	--	--	--	--	111.21	-65.57

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Shareholder's Funds	321.75	408.73	590.33	453.70	535.03	424.97
Minority Interest	--	--	--	--	--	0.40
Non-Current Liabilities	1.41	1.90	0.85	2.15	3.59	0.07
Current Liabilities	40.63	37.74	30.65	28.14	22.50	11.75
Total Liabilities	404.42	448.37	621.82	484.18	561.12	437.19

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Non-Current Assets	21.81	61.62	207.16	3.99	86.65	140.62
Current Assets	341.97	386.76	414.67	480.19	474.47	296.56
Total Assets	404.42	448.37	621.82	484.18	561.12	437.19
Total Debt*	2.07	2.68	2.15	3.59	5.19	--
Net Current Assets	301.35	349.02	384.02	452.05	451.97	284.82

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Cash From Operating Activities	--	-175.75	-145.30	-134.28	-126.66	-43.43
Cash Flow from Investing Activities	--	179.99	-136.31	35.81	248.98	-333.78
Cash from Financing Activities	--	1.09	266.19	40.75	-25.93	268.78
Net Cash Inflow / Outflow	--	--	--	--	96.38	-108.42

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Adjusted EPS ($)	-3.43	-3.71	-2.86	-3.58	2.43	-1.49
Cash EPS ($)	--	-3.71	-2.85	-3.57	2.43	-1.49
Adjusted Book Value ($)	--	6.90	10.08	10.60	11.69	9.74
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.97	-2.48	-3.14	-2.77	-1.00
Free Cash Flow per Share ($)	--	-2.97	-2.48	-3.14	-2.79	-1.01

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
ROCE (%)	--	-43.81	-31.89	-30.71	23.05	-20.85
ROE (%)	-56.04	-44.02	-32.06	-30.98	23.17	-20.85
ROA (%)	-42.97	-41.09	-30.27	-29.30	22.28	-19.95
EBIT Margin (%)	--	--	--	--	--	-358.73
Net Margin (%)	--	--	--	--	1,667.88	-335.05
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	-1.00	--
EBIT Growth (%)	-1.01	-31.30	12.16	-44.28	-94.45	-12.63
Net Profit Growth (%)	1.00	-31.36	-9.28	-237.72	270.99	-27.91
EPS Growth (%)	2.63	-0.30	0.20	-2.47	2.63	-0.23
Book Value Growth (%)	-37.26	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Price / Earnings	--	-2.79	-4.26	-2.85	4.34	-10.35
Price / Book Value	4.36	1.50	1.21	0.96	0.90	1.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.46	-1.08	-1.89	0.14	-0.16	-5.64
Close Price ($)	18.21	10.35	12.18	10.19	10.55	15.43
High Price ($)	19.43	13.33	30.19	13.74	18.46	59.85
Low Price ($)	5.68	5.68	10.00	7.68	7.30	14.41
Market Cap ($ Cr)	1,357.61	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Debt to Equity	--	0.01	0.00	0.01	0.01	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	--
Current Ratio	8.42	10.25	13.53	17.07	21.09	25.25
Quick Ratio	8.42	--	--	17.26	--	--
Interest Coverage	--	--	--	--	-0.23	-1.04

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	0.06
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-6,445.59	-6,362.42	--	--
Payable days	--	1,481.55	2,491.70	3,035.70	11,446.46	44,271.06
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.